{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:28:03Z","timestamp":1792081683610,"version":"4.4.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["mgmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.ymgme.2017.12.431","type":"journal-article","created":{"date-parts":[[2017,12,22]],"date-time":"2017-12-22T08:17:29Z","timestamp":1513930649000},"page":"76-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Rapid screening for lipid storage disorders using biochemical markers. Expert center data and review of the literature"],"prefix":"10.1016","volume":"123","author":[{"given":"M.","family":"Voorink-Moret","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.M.I.","family":"Goorden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.B.P.","family":"van Kuilenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.A.","family":"Wijburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.M.","family":"Ghauharali-van der Vlugt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.S.","family":"Beers-Stet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Zoetekouw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Kulik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.E.M.","family":"Hollak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.M.","family":"Vaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ymgme.2017.12.431_bb0005","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1515\/cclm-2016-0340","article-title":"Diagnosis of sphingolipidoses: a new simultaneous measurement of lysosphingolipids by LC-MS\/MS","volume":"55","author":"Polo","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"issue":"7","key":"10.1016\/j.ymgme.2017.12.431_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181700","article-title":"LC-MS\/MS multiplex analysis of lysosphingolipids in plasma and amniotic fluid: a novel tool for the screening of sphingolipidoses and Niemann-Pick type C disease","volume":"12","author":"Pettazzoni","year":"2017","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.ymgme.2017.12.431_bb0015","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1073\/pnas.0712309105","article-title":"Elevated globotriaosylsphingosine is a hallmark of Fabry disease","volume":"105","author":"Aerts","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"16","key":"10.1016\/j.ymgme.2017.12.431_bb0020","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1182\/blood-2011-05-352971","article-title":"Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response","volume":"118","author":"Dekker","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2017.12.431_bb0025","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cca.2013.01.017","article-title":"Determination of psychosine concentration in dried blood spots from newborns that were identified via newborn screening to be at risk for Krabbe disease","volume":"419","author":"Chuang","year":"2013","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"10.1016\/j.ymgme.2017.12.431_bb0030","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ymgme.2013.11.012","article-title":"Lyso-sphingomyelin is elevated in dried blood spots of Niemann-Pick B patients","volume":"111","author":"Chuang","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2017.12.431_bb0035","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13023-015-0274-1","article-title":"A novel, highly sensitive and specific biomarker for Niemann-Pick type C1 disease","volume":"10","author":"Giese","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"issue":"10","key":"10.1016\/j.ymgme.2017.12.431_bb0040","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1194\/jlr.M060343","article-title":"Cholestane-3beta,5alpha,6beta-triol: high levels in Niemann-Pick type C, cerebrotendinous xanthomatosis, and lysosomal acid lipase deficiency","volume":"56","author":"Pajares","year":"2015","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2017.12.431_bb0045","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jsbmb.2016.02.030","article-title":"Determination of serum cholestane-3beta,5alpha,6beta-triol by gas chromatography-mass spectrometry for identification of Niemann-Pick type C (NPC) disease","volume":"169","author":"Kannenberg","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"3","key":"10.1016\/j.ymgme.2017.12.431_bb0050","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1194\/jlr.M061978","article-title":"Evaluation of plasma cholestane-3beta,5alpha,6beta-triol and 7-ketocholesterol in inherited disorders related to cholesterol metabolism","volume":"57","author":"Boenzi","year":"2016","journal-title":"J. Lipid Res."},{"issue":"9","key":"10.1016\/j.ymgme.2017.12.431_bb0055","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.clinbiochem.2015.03.007","article-title":"LC-MS\/MS based assay and reference intervals in children and adolescents for oxysterols elevated in Niemann-Pick diseases","volume":"48","author":"Klinke","year":"2015","journal-title":"Clin. Biochem."},{"issue":"7","key":"10.1016\/j.ymgme.2017.12.431_bb0060","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1194\/jlr.D015735","article-title":"A sensitive and specific LC-MS\/MS method for rapid diagnosis of Niemann-Pick C1 disease from human plasma","volume":"52","author":"Jiang","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2017.12.431_bb0065","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cca.2016.01.003","article-title":"Comprehensive evaluation of plasma 7-ketocholesterol and cholestan-3beta,5alpha,6beta-Triol in an Italian cohort of patients affected by Niemann-Pick disease due to NPC1 and SMPD1 mutations","volume":"455","author":"Romanello","year":"2016","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2017.12.431_bb0070","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ebiom.2015.12.018","article-title":"Rapid diagnosis of 83 patients with Niemann Pick type C disease and related cholesterol transport disorders by cholestantriol screening","volume":"4","author":"Reunert","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ymgme.2017.12.431_bb0075","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cca.2016.05.015","article-title":"Selective screening of Niemann-Pick type C Brazilian patients by cholestane-3beta,5alpha,6beta-triol and chitotriosidase measurements followed by filipin staining and NPC1\/NPC2 gene analysis","volume":"459","author":"Ribas","year":"2016","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2017.12.431_bb0080","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.chroma.2015.11.015","article-title":"Quantification of oxysterols in human plasma and red blood cells by liquid chromatography high-resolution tandem mass spectrometry","volume":"1439","author":"Pataj","year":"2016","journal-title":"J. Chromatogr. A"},{"issue":"56","key":"10.1016\/j.ymgme.2017.12.431_bb0085","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001417","article-title":"Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-pick C1 disease","volume":"2","author":"Porter","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymgme.2017.12.431_bb0090","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/8904_2015_423","article-title":"Niemann-Pick type C-2 disease: identification by analysis of plasma cholestane-3beta,5alpha,6beta-triol and further insight into the clinical phenotype","volume":"23","author":"Reunert","year":"2015","journal-title":"JIMD Rep."},{"issue":"4","key":"10.1016\/j.ymgme.2017.12.431_bb0095","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ymgme.2016.06.004","article-title":"Diagnostic tests for Niemann-Pick disease type C (NP-C): a critical review","volume":"118","author":"Vanier","year":"2016","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2017.12.431_bb0100","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1194\/jlr.D044024","article-title":"Determination of 7-ketocholesterol in plasma by LC-MS for rapid diagnosis of acid SMase-deficient Niemann-Pick disease","volume":"55","author":"Lin","year":"2014","journal-title":"J. Lipid Res."},{"issue":"3","key":"10.1016\/j.ymgme.2017.12.431_bb0105","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1172\/JCI117084","article-title":"Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease","volume":"93","author":"Hollak","year":"1994","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.ymgme.2017.12.431_bb0110","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10545-005-4416-9","article-title":"Plasma chitotriosidase and CCL18: early biochemical surrogate markers in type B Niemann-Pick disease","volume":"28","author":"Brinkman","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2017.12.431_bb0115","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ymgme.2017.05.001","article-title":"Favourable effect of early versus late start of enzyme replacement therapy on plasma globotriaosylsphingosine levels in men with classical Fabry disease","volume":"121","author":"Arends","year":"2017","journal-title":"Mol. Genet. Metab."},{"issue":"457","key":"10.1016\/j.ymgme.2017.12.431_bb0120","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1651-2227.2007.00641.x","article-title":"Biomarkers for lysosomal storage disorders: identification and application as exemplified by chitotriosidase in Gaucher disease","volume":"97","author":"Aerts","year":"2008","journal-title":"Acta Paediatr."},{"issue":"1","key":"10.1016\/j.ymgme.2017.12.431_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jmedgenet-2013-101857","article-title":"A systematic review on screening for Fabry disease: prevalence of individuals with genetic variants of unknown significance","volume":"51","author":"van der Tol","year":"2014","journal-title":"J. Med. Genet."},{"issue":"4","key":"10.1016\/j.ymgme.2017.12.431_bb0130","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0950-3536(97)80034-0","article-title":"Plasma and metabolic abnormalities in Gaucher's disease","volume":"10","author":"Aerts","year":"1997","journal-title":"Baillieres Clin. Haematol."},{"issue":"8","key":"10.1016\/j.ymgme.2017.12.431_bb0135","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/o59-099","article-title":"A rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can. J. Biochem. Physiol."},{"issue":"2","key":"10.1016\/j.ymgme.2017.12.431_bb0140","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cca.2007.02.042","article-title":"Monitoring of Gaucher patients with a novel chitotriosidase assay","volume":"381","author":"Schoonhoven","year":"2007","journal-title":"Clin. Chim. Acta"},{"issue":"42","key":"10.1016\/j.ymgme.2017.12.431_bb0145","doi-asserted-by":"crossref","first-page":"40911","DOI":"10.1074\/jbc.M301804200","article-title":"Transglycosidase activity of chitotriosidase: improved enzymatic assay for the human macrophage chitinase","volume":"278","author":"Aguilera","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2017.12.431_bb0150","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ab.2017.02.019","article-title":"Quantitation of plasmatic lysosphingomyelin and lysosphingomyelin-509 for differential screening of Niemann-Pick A\/B and C diseases","volume":"252","author":"Kuchar","year":"2017","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ymgme.2017.12.431_bb0155","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cca.2016.03.004","article-title":"Clinical evaluation of chitotriosidase enzyme activity in Gaucher and Niemann Pick A\/B diseases: a retrospective study from India","volume":"457","author":"Kadali","year":"2016","journal-title":"Clin. Chim. Acta"},{"issue":"10","key":"10.1016\/j.ymgme.2017.12.431_bb0160","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.clinbiochem.2004.06.008","article-title":"Biochemical characterization of chitotriosidase enzyme: comparison between normal individuals and patients with Gaucher and with Niemann-Pick diseases","volume":"37","author":"Wajner","year":"2004","journal-title":"Clin. Biochem."},{"issue":"2","key":"10.1016\/j.ymgme.2017.12.431_bb0165","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s12098-009-0249-0","article-title":"Plasma chitotriosidase activity in children with lysosomal storage disorders","volume":"77","author":"Sheth","year":"2010","journal-title":"Indian J. Pediatr."},{"issue":"12","key":"10.1016\/j.ymgme.2017.12.431_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114669","article-title":"Plasma lysosphingomyelin demonstrates great potential as a diagnostic biomarker for Niemann-Pick disease type C in a retrospective study","volume":"9","author":"Welford","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ymgme.2017.12.431_bb0175","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ymgme.2015.12.006","article-title":"Lyso-glycosphingolipid abnormalities in different murine models of lysosomal storage disorders","volume":"117","author":"Ferraz","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2017.12.431_bb0180","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jsbmb.2016.02.030","article-title":"Determination of serum cholestane-3beta,5alpha,6beta-triol by gas chromatography-mass spectrometry for identification of Niemann-Pick type C (NPC) disease","volume":"169","author":"Kannenberg","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"1","key":"10.1016\/j.ymgme.2017.12.431_bb0185","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12967-017-1146-3","article-title":"Assessment of plasma chitotriosidase activity, CCL18\/PARC concentration and NP-C suspicion index in the diagnosis of Niemann-Pick disease type C: a prospective observational study","volume":"15","author":"De Castro-Oros","year":"2017","journal-title":"J. Transl. Med."},{"issue":"5\u20136","key":"10.1016\/j.ymgme.2017.12.431_bb0190","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.clinbiochem.2006.12.003","article-title":"Comparison between the biochemical properties of plasma chitotriosidase from normal individuals and from patients with Gaucher disease, GM1-gangliosidosis, Krabbe disease and heterozygotes for Gaucher disease","volume":"40","author":"Wajner","year":"2007","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ymgme.2017.12.431_bb0195","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.cca.2017.01.014","article-title":"Simultaneous quantitation of sphingoid bases by UPLC-ESI-MS\/MS with identical 13C-encoded internal standards","volume":"466","author":"Mirzaian","year":"2017","journal-title":"Clin. Chim. Acta"},{"issue":"11","key":"10.1016\/j.ymgme.2017.12.431_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079732","article-title":"Glucosylsphingosine is a highly sensitive and specific biomarker for primary diagnostic and follow-up monitoring in Gaucher disease in a non-Jewish, Caucasian cohort of Gaucher disease patients","volume":"8","author":"Rolfs","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2017.12.431_bb0205","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.chroma.2017.10.038","article-title":"Optimization of ultra-high pressure liquid chromatography - tandem mass spectrometry determination in plasma and red blood cells of four sphingolipids and their evaluation as biomarker candidates of Gaucher's disease","volume":"1525","author":"Chipeaux","year":"2017","journal-title":"J. Chromatogr. A"},{"issue":"11","key":"10.1016\/j.ymgme.2017.12.431_bb0210","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/ajh.24491","article-title":"Glucosylsphingosine is a key biomarker of Gaucher disease","volume":"91","author":"Murugesan","year":"2016","journal-title":"Am. J. Hematol."},{"issue":"6","key":"10.1016\/j.ymgme.2017.12.431_bb0215","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/1873-3468.12104","article-title":"Lysosomal glycosphingolipid catabolism by acid ceramidase: formation of glycosphingoid bases during deficiency of glycosidases","volume":"590","author":"Ferraz","year":"2016","journal-title":"FEBS Lett."},{"issue":"4","key":"10.1016\/j.ymgme.2017.12.431_bb0220","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.bcmd.2015.01.006","article-title":"Mass spectrometric quantification of glucosylsphingosine in plasma and urine of type 1 Gaucher patients using an isotope standard","volume":"54","author":"Mirzaian","year":"2015","journal-title":"Blood Cells Mol. Dis."},{"issue":"3","key":"10.1016\/j.ymgme.2017.12.431_bb0225","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/cge.12753","article-title":"Clinical, biochemical and molecular characterization of prosaposin deficiency","volume":"90","author":"Motta","year":"2016","journal-title":"Clin. Genet."},{"issue":"4","key":"10.1016\/j.ymgme.2017.12.431_bb0230","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/jmedgenet-2014-102872","article-title":"Plasma globotriaosylsphingosine in relation to phenotypes of Fabry disease","volume":"52","author":"Smid","year":"2015","journal-title":"J. Med. Genet."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2017.12.431_bb0235","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ymgme.2017.08.004","article-title":"A simple method for quantification of plasma globotriaosylsphingosine: utility for Fabry disease","volume":"122","author":"Talbot","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2017.12.431_bb0240","article-title":"Genotype, phenotype and disease severity reflected by serum LysoGb3 levels in patients with Fabry disease","author":"Nowak","year":"2017","journal-title":"Mol. Genet. Metab."},{"issue":"5","key":"10.1016\/j.ymgme.2017.12.431_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127048","article-title":"Nano-LC-MS\/MS for quantification of Lyso-Gb3 and its analogues reveals a useful biomarker for Fabry disease","volume":"10","author":"Sueoka","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ymgme.2017.12.431_bb0250","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1373\/clinchem.2012.192138","article-title":"Quantification of globotriaosylsphingosine in plasma and urine of fabry patients by stable isotope ultraperformance liquid chromatography-tandem mass spectrometry","volume":"59","author":"Gold","year":"2013","journal-title":"Clin. Chem."},{"issue":"3","key":"10.1016\/j.ymgme.2017.12.431_bb0255","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ymgme.2010.03.020","article-title":"Plasma globotriaosylsphingosine as a biomarker of Fabry disease","volume":"100","author":"Togawa","year":"2010","journal-title":"Mol. Genet. Metab."},{"issue":"9","key":"10.1016\/j.ymgme.2017.12.431_bb0260","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.bbadis.2010.05.003","article-title":"Plasma globotriaosylsphingosine: diagnostic value and relation to clinical manifestations of Fabry disease","volume":"1802","author":"Rombach","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2017.12.431_bb0265","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ymgme.2016.10.006","article-title":"Plasma LysoGb3: a useful biomarker for the diagnosis and treatment of Fabry disease heterozygotes","volume":"120","author":"Nowak","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2017.12.431_bb0270","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ab.2017.02.019","article-title":"Quantitation of plasmatic lysosphingomyelin and lysosphingomyelin-509 for differential screening of Niemann-Pick A\/B and C diseases","volume":"252","author":"Kuchar","year":"2017","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ymgme.2017.12.431_bb0275","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1750-1172-9-82","article-title":"Diagnosis of Niemann-pick disease type C with 7-ketocholesterol screening followed by NPC1\/NPC2 gene mutation confirmation in Chinese patients","volume":"9","author":"Zhang","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"issue":"12","key":"10.1016\/j.ymgme.2017.12.431_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144958","article-title":"Distributions of globotriaosylceramide isoforms, and globotriaosylsphingosine and its analogues in an alpha-galactosidase a knockout mouse, a model of Fabry disease","volume":"10","author":"Sueoka","year":"2015","journal-title":"PLoS One"},{"issue":"337","key":"10.1016\/j.ymgme.2017.12.431_bb0285","doi-asserted-by":"crossref","first-page":"337ra63","DOI":"10.1126\/scitranslmed.aaf2326","article-title":"Development of a bile acid-based newborn screen for Niemann-Pick disease type C","volume":"8","author":"Jiang","year":"2016","journal-title":"Sci. Transl. Med."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2017.12.431_bb0290","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cca.2009.09.034","article-title":"Plasma chitotriosidase and CCL18 as surrogate markers for granulomatous macrophages in sarcoidosis","volume":"411","author":"Boot","year":"2010","journal-title":"Clin. Chim. Acta"},{"issue":"6","key":"10.1016\/j.ymgme.2017.12.431_bb0295","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.clinbiochem.2015.11.009","article-title":"Association of chitotriosidase enzyme activity and genotype with the risk of nephropathy in type 2 diabetes","volume":"49","author":"Elmonem","year":"2016","journal-title":"Clin. Biochem."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719217306789?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719217306789?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T15:55:16Z","timestamp":1533657316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719217306789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S1096719217306789"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2017.12.431","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapid screening for lipid storage disorders using biochemical markers. Expert center data and review of the literature","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2017.12.431","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}